RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
120 hedge funds and large institutions have $1.05B invested in Revance Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $1.25B → $1.05B (-$196M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
120
Holding in Top 10
2
Calls
$3.14M
Puts
$1.35M
Top Buyers
| 1 | +$19.3M | |
| 2 | +$12.2M | |
| 3 | +$9.84M | |
| 4 |
BlackRock
New York
|
+$7.46M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.42M |
Top Sellers
| 1 | -$47.4M | |
| 2 | -$35.8M | |
| 3 | -$10.7M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$8.45M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$6.81M |